Coumarin derivatives with anticancer activities: An update
- PMID: 32383190
- DOI: 10.1002/ardp.202000025
Coumarin derivatives with anticancer activities: An update
Abstract
Cancer can invade or spread to almost all parts of the body. The increasing morbidity and high mortality of cancer create a great demand for the development of novel anticancer drugs. Coumarin derivatives are ubiquitous in nature and can readily interact with diverse enzymes and receptors in cancer cells via weak bond interactions; hence, coumarin is a highly privileged pharmacophore for the development of novel anticancer agents. This review will focus on the recent development of coumarin hybrids as potential anticancer agents covering articles published from 2019 to 2020.
Keywords: anticancer; coumarin; drug discovery; mechanism of action.
© 2020 Deutsche Pharmazeutische Gesellschaft.
References
REFERENCES
- 
    - R. L. Siegel, A. Jemal, R. C. Wender, T. Gansler, J. Ma, O. W. Brawley, CA Cancer J. Clin. 2018, 68, 329.
 
- 
    - R. L. Siegel, K. D. Miller, A. Jemal, CA Cancer J. Clin. 2020, 70, 7.
 
- 
    - World Health Organization. Cancer: Key facts. 2020 (accessed 2020). http://www.who.int/news-room/fact-sheets/detail/cancer
 
- 
    - International Agency for Research on Cancer. Cancer Tomorrow. 2020. (accessed: November 16, 2019). https://gco.iarc.fr/tomorrow/graphic-isotype?type=0&population=900&a...
 
- 
    - W. Zheng, Y. Zhao, Q. Luo, Y. Zhang, K. Wu, F. Wang, Curr. Top. Med. Chem. 2017, 17, 3084.
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
 
        